'Factor xa' presentation slideshows

1.06k views • 92 slides

Relative Binding Free Energies for Protein-Inhibitor Complexes

Relative Binding Free Energies for Protein-Inhibitor Complexes. CATFEE: Critical Assessment of Techniques for Free Energy Evaluation. Blind test of 10 compounds. Determine relative affinities to Factor Xa, Thrombin and Trypsin. Our Interest : Test protocols and convergence.

951 views • 78 slides

DIRECT FACTOR Xa INHIBITOR AS ANTICOAGULANT

For more presentations and information visit http://www.pharmaxchange.info. DIRECT FACTOR Xa INHIBITOR AS ANTICOAGULANT. PREET PAL SINGH SIDHU DEPT OF MEDICINAL CHEMISTRY SCHOOL OF PHARMACY, VCU. OVERVIEW. For more presentations and information visit http://www.pharmaxchange.info.

832 views • 37 slides

Welcome Ask The Experts March 24-27, 2007 New Orleans, LA

Welcome Ask The Experts March 24-27, 2007 New Orleans, LA. Are all Xa Inhibitors the Same? Alexander G. G. Turpie, MD Professor of Medicine McMaster University Hamilton, Ontario, Canada. Antithrombotics That Have Changed Clinical Practice. Anticoagulants Low-molecular-weight heparin

536 views • 35 slides

Characterization of antithrombin -specific RNA aptamers for use in anticoagulant therapy

Characterization of antithrombin -specific RNA aptamers for use in anticoagulant therapy. Yolanda M. Fortenberry, Ph.D. Hematology 2014 Conference Johns Hopkins University School of Medicine. What are aptamers?. Synthetic ssDNA or RNA molecules.

534 views • 35 slides

Parenteral Anticoagulant

Parenteral Anticoagulant. BY : Maha khalid Supervisor : Pro Dr Seham Hafez. Parenteral Anticoagulant. UFH & LMWH all consist of high MW molecules that Are highly ionized (they don't absorbed from GIT they must given by IV infusion or deep SC injection. ( never IM ). LMWH.

1.01k views • 34 slides

Anticoagulant Therapy

Anticoagulant Therapy. Deep venous thrombosis. Pulmonary embolism. Coagulation Cascade. Antiagoagulant therapy is aimed at: preventing clot in patients at risk Prevent clot extension/ embolisation Deep venous thrombosis (DVT) & pulmonary embolism (PE)

1.15k views • 32 slides

Anticoagulant Therapy

Anticoagulant Therapy. Deep venous thrombosis. Pulmonary embolism. Coagulation Cascade. Antiagoagulant therapy is aimed at: preventing clot in patients at risk Prevent clot extension/ embolisation Deep venous thrombosis (DVT) & pulmonary embolism (PE)

918 views • 32 slides

Management of Dabigatran and Rivaroxaban

Management of Dabigatran and Rivaroxaban. Xuan Wang July 27, 2012. Introduction to dabigatran and rivaroxaban RELY trial ROCKET AF trial Monitoring Emergency management Prevalence at Vanderbilt. Outline. Conventional Anticoagulants.

355 views • 32 slides

A Multilingual , Relational Database of Health Evidence

482 views • 31 slides

Consequences of thrombus

Consequences of thrombus. Anticoagulant Therapy. Coagulation Cascade. Anticoagulant therapy is aimed to: Prevent clot in patients at risk Prevent clot extension/ embolism Deep venous thrombosis (DVT) & pulmonary embolism (PE ).

448 views • 31 slides

Heparin

Heparin. Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School. Heparin. Chemistry Low molecular weight fractions of heparin have a high affinity for ACTIVATED FACTOR X (Xa), but have less of an effect on thrombin. I. I. I. I. I. I. I. V.

3.26k views • 27 slides

Pribnow box (-10) T 89 A 99 T 50 A 65 A 65 T 100 s 70 binding site (-35)

Pribnow box (-10) T 89 A 99 T 50 A 65 A 65 T 100 s 70 binding site (-35) T 85 T 83 G 81 A 61 C 69 A 52. pMAL vectors : ColE1 ori ; M13 ori ; Ptac ; rrnB terminators ; lacI q ; bla Fusion construct : malE - DDDDDDDDDD - IEGR - MCS - lacZ a

342 views • 24 slides

Expression of clones genes

Expression of clones genes. a.o. Primrose & Twyman, 7th edition, pp.81-93 Primrose, Twyman & Old, 6th edition, pp.70-83. IPTG-induced expression of RP4 proteins : (A) DNA primase (118 and 80 kDa proteins) ; (B) 16.5 and

479 views • 23 slides

Coag Made Easy

Coag Made Easy. Alice Ma, M.D. University of North Carolina-Chapel Hill Division of Hematology. August 26, 2004. Coagulation made easy. The PTT Pathway. The PT Pathway. Coagulation made easy. The PTT Pathway. The PT Pathway. X.

1.77k views • 15 slides

Cold Shock Vectors

349 views • 15 slides

The role of anticoagulation in venous shunts

284 views • 12 slides

Spain Coagulation Market | Global Industry Analysis, Share and Forecast 2018

Report explores business and technological trends in Spanish coagulation testing market, provides estimates of test volume, sales and market shares of leading competitors

124 views • 9 slides

Anticoagulants Market : Analysis and Opportunity Assessment 2018-2026

Rise in standard of health care facilities and availability of advanced treatment options boost life expectancy rates across the world, which in turn increases the geriatric population. This drives the need of anticoagulant products among the population. Additionally, rise in adoption of Novel Oral Anticoagulants (NOACs) boosts the growth of the global anticoagulant market.

72 views • 7 slides

Saudi Arabia Hemostasis Diagnostic Analyzers and Reagents Market - Forecasts from 2019 to 2023

Market Reports On Saudi Arabia Provides the Trending Market Research Report on u201cSaudi Arabia Hemostasis Diagnostic Analyzers and Reagents Market - Forecasts from 2019 to 2023u201d under Healthcare category. Request a free sample copy of Hemostasis Diagnostic Analyzers and Reagents Market Report @ http://www.marketreportsonsaudiarabia.com/marketreports/sample/reports/1581533

40 views • 3 slides